Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting (Tables)

v3.24.1.u1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following tables present financial information for the Company’s two operating business segments:
Three Months Ended
March 31,
2024 2023
Revenues:
Corporate clinics $ 17,537,504  $ 17,127,957 
Franchise operations 12,184,662  11,172,863 
Total revenues $ 29,722,166  $ 28,300,820 
Depreciation and amortization:
Corporate clinics 1,104,232  1,927,091 
Franchise operations 219,250  198,974 
Corporate administration 80,424  88,990 
Total depreciation and amortization $ 1,403,906  $ 2,215,055 
Segment operating income (loss):
Corporate clinics $ 1,486,910  $ (422,053)
Franchise operations 5,337,948  4,541,899 
Total segment operating income $ 6,824,858  $ 4,119,846 
Reconciliation of total segment operating income to consolidated earnings before income taxes:
Total segment operating income $ 6,824,858  $ 4,119,846 
Unallocated corporate (5,734,582) (4,772,955)
Consolidated income (loss) from operations 1,090,276  (653,109)
Other income, net 35,630  3,821,162 
Income before income tax benefit $ 1,125,906  $ 3,168,053 
Schedule of Reconciliation of Assets from Segment to Consolidated
March 31,
2024
December 31,
2023
Segment assets:
Corporate clinics $ 50,809,138  $ 52,210,617 
Franchise operations 11,928,759 10,521,582
Total segment assets 62,737,897 62,732,199
Unallocated cash and cash equivalents and restricted cash 19,666,842 19,214,292
Unallocated property and equipment 561,340 2,843,491
Other unallocated assets 2,717,475 2,360,877
Total assets $ 85,683,554  $ 87,150,859